Histogen, a San Diego-based biotechnology company, is developing health products based on replicating the regenerative capacity of newborn cells grown under embryonic conditions. CEO Gail Naughton explains the company's "virtual" business model and how U.S. biotechs can do business in China.
Link to this comment:
All Comments (0)